FRIDAY, July 26, 2024 (HealthDay News) — People diagnosed with one of the most common inherited heart arrhythmias, called Long QT syndrome (LQTS), can safely engage in vigorous exercise without any added risk for sudden death or cardiac arrest, a new study finds. “Arrhythmic events were low in these appropriatelyContinue Reading

TUESDAY, June 25, 2024 (HealthDay News) — For decades, millions of Americans popped a low-dose aspirin each day to lower their heart risks. Then, accumulated data prompted the nation’s two leading cardiology groups — the American College of Cardiology and the American Heart Association — to overturn advisories in 2019Continue Reading

TUESDAY, June 25, 2024 (HealthDay News) — A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows. Fenofibrate (Tricor) has been approved since 2004 as a means of lowering cholesterol. Now, this new study shows that fenofibrate also can reduce theContinue Reading